These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28581514)

  • 1. ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.
    Pérez-Alea M; McGrail K; Sánchez-Redondo S; Ferrer B; Fournet G; Cortés J; Muñoz E; Hernandez-Losa J; Tenbaum S; Martin G; Costello R; Ceylan I; Garcia-Patos V; Recio JA
    Oncogene; 2017 Oct; 36(41):5695-5708. PubMed ID: 28581514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.
    Rebollido-Rios R; Venton G; Sánchez-Redondo S; Iglesias I Felip C; Fournet G; González E; Romero Fernández W; Borroto Escuela DO; Di Stefano B; Penarroche-Díaz R; Martin G; Ceylan I; Costello R; Perez-Alea M
    Oncogene; 2020 Mar; 39(13):2756-2771. PubMed ID: 32015486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors.
    Venton G; Pérez-Alea M; Baier C; Fournet G; Quash G; Labiad Y; Martin G; Sanderson F; Poullin P; Suchon P; Farnault L; Nguyen C; Brunet C; Ceylan I; Costello RT
    Blood Cancer J; 2016 Sep; 6(9):e469. PubMed ID: 27611922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation.
    Gasque Schoof CR; Izzotti A; Jasiulionis MG; Vasques Ldos R
    Biomed Res Int; 2015; 2015():634749. PubMed ID: 26618174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.
    Luo Y; Dallaglio K; Chen Y; Robinson WA; Robinson SE; McCarter MD; Wang J; Gonzalez R; Thompson DC; Norris DA; Roop DR; Vasiliou V; Fujita M
    Stem Cells; 2012 Oct; 30(10):2100-13. PubMed ID: 22887839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3.
    Thomas ML; de Antueno R; Coyle KM; Sultan M; Cruickshank BM; Giacomantonio MA; Giacomantonio CA; Duncan R; Marcato P
    Mol Oncol; 2016 Nov; 10(9):1485-1496. PubMed ID: 27592281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes.
    Samson JM; Ravindran Menon D; Smith DE; Baird E; Kitano T; Gao D; Tan AC; Fujita M
    Chem Biol Interact; 2019 Dec; 314():108822. PubMed ID: 31580832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells.
    Shidal C; Al-Rayyan N; Yaddanapudi K; Davis KR
    Oncotarget; 2016 Dec; 7(51):84128-84141. PubMed ID: 27566591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
    Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
    Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma.
    Yue L; Huang ZM; Fong S; Leong S; Jakowatz JG; Charruyer-Reinwald A; Wei M; Ghadially R
    Melanoma Res; 2015 Apr; 25(2):138-48. PubMed ID: 25643237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis.
    Contador-Troca M; Alvarez-Barrientos A; Merino JM; Morales-Hernández A; Rodríguez MI; Rey-Barroso J; Barrasa E; Cerezo-Guisado MI; Catalina-Fernández I; Sáenz-Santamaría J; Oliver FJ; Fernandez-Salguero PM
    Mol Cancer; 2015 Aug; 14():148. PubMed ID: 26242870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel competitive irreversible inhibitors of aldehyde dehydrogenase (ALDH1): restoration of chemosensitivity of L1210 cells overexpressing ALDH1 and induction of apoptosis in BAF(3) cells overexpressing bcl(2).
    Quash G; Fournet G; Chantepie J; Gore J; Ardiet C; Ardail D; Michal Y; Reichert U
    Biochem Pharmacol; 2002 Oct; 64(8):1279-92. PubMed ID: 12234608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells and human malignant melanoma.
    Schatton T; Frank MH
    Pigment Cell Melanoma Res; 2008 Feb; 21(1):39-55. PubMed ID: 18353142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
    Flahaut M; Jauquier N; Chevalier N; Nardou K; Balmas Bourloud K; Joseph JM; Barras D; Widmann C; Gross N; Renella R; Mühlethaler-Mottet A
    BMC Cancer; 2016 Oct; 16(1):781. PubMed ID: 27724856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALDH1A3-acetaldehyde metabolism potentiates transcriptional heterogeneity in melanoma.
    Lu Y; Travnickova J; Badonyi M; Rambow F; Coates A; Khan Z; Marques J; Murphy LC; Garcia-Martinez P; Marais R; Louphrasitthiphol P; Chan AHY; Schofield CJ; von Kriegsheim A; Marsh JA; Pavet V; Sansom OJ; Illingworth RS; Patton EE
    Cell Rep; 2024 Jul; 43(7):114406. PubMed ID: 38963759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of DNA repair gene Ercc1 as a novel target in melanoma.
    Song L; Ritchie AM; McNeil EM; Li W; Melton DW
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):966-71. PubMed ID: 21722328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
    McNeal AS; Liu K; Nakhate V; Natale CA; Duperret EK; Capell BC; Dentchev T; Berger SL; Herlyn M; Seykora JT; Ridky TW
    Cancer Discov; 2015 Oct; 5(10):1072-85. PubMed ID: 26183406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo anti-uveal melanoma activity of JSL-1, a novel HDAC inhibitor.
    Wang Y; Liu M; Jin Y; Jiang S; Pan J
    Cancer Lett; 2017 Aug; 400():47-60. PubMed ID: 28455241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment.
    Seftor EA; Brown KM; Chin L; Kirschmann DA; Wheaton WW; Protopopov A; Feng B; Balagurunathan Y; Trent JM; Nickoloff BJ; Seftor RE; Hendrix MJ
    Cancer Res; 2005 Nov; 65(22):10164-9. PubMed ID: 16288000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting melanocyte and melanoma stem cells by 8-hydroxy-2-dipropylaminotetralin.
    Bonchak JG; Eby JM; Willenborg KA; Chrobak D; Henning SW; Krzywiec A; Johnson SL; Le Poole IC
    Arch Biochem Biophys; 2014 Dec; 563():71-8. PubMed ID: 25132642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.